Lite Strategy, Inc.

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

LITSNasdaqHealthcareBiotechnology
$0.87 +0.05 (+6.50%)

Company Overview

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Price Chart

Historical Trend (Absolute Values)
LITS Price
05/1805/2706/03

Financial Metrics

Market Capitalization$25.48M
P/E Ratio
Earnings Per Share (EPS)-$2
Dividend Yield
Beta (Volatility)0.083
Price to Book (P/B)0.3892
52-Week Range$0.77 - $9.00

LAST SCRARED: June 3, 2026

Compare LITS

Analyze valuation multiples and growth parameters side-by-side with other public equities.

Compare Stock Now
VersusHub

© 2026 VersusHub. All rights reserved.